The investigators will compare the efficacy of Interleukin-6 (IL-6) as a better indicator than procalcitonin in burn patients with sepsis or septic shock regarding success of treatment and early ICU discharge.
Interleukin 6 and procalcitonin will be sampled for all patients on days 1, 3, 7, and 10. Treatment plan will be initiated to all patients according to the burn ICU protocol. According to the lab results, interleukin 6 and procalcitonin will guide the investigators to take decisions regarding clinical improvement and ICU stay.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
70
Interleukin 6 and procalcitonin will be sampled for all patients on days 1, 3, 7, and 10
Ain Shams University
Cairo, Egypt
RECRUITINGOccurrence of sepsis and septic shock
Prediction of occurrence of sepsis and septic shock
Time frame: From day 1 to day 10 in burn ICU
Length of ICU stay
Response to treatment and length of ICU stay for over one month
Time frame: One month after ICU admission
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.